KAI-1678

DB16211Investigational

KAI-1678 is under investigation in clinical trial NCT01106716 (Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia).

Mechanism: Pharmacologically active on Protein kinase C epsilon type
Curator reviewed
Code names: KAI-1678 · KP-1678

Resolves to

Compound

UNII32P8I5VL5ACAS1041004-14-1

Targets

Q02156PRKCE

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with KAI-1678, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account